Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02928770 · ClinicalTrials.gov registry record · NA
A Disposable Device NAS to Treat Obstructive Sleep Apnea and Snoring
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 32
- Enrollment target
NCT02928770: Completed NA study, sponsored by Stanford University.
NCT02928770 is a NA study that has completed, run by Stanford University. The registered enrollment target is 32 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02928770, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
Study Summary
The purpose of this research study is to test a new approach for treating patients with obstructive sleep apnea and/or snoring. The new nasal device, nastent (NAS: nasal airway stent), appears to be a useful alternative or additive treatment.
Interventions
- DEVICE Nastent
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2015-02 |
| Est. Completion | 2017-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02928770
The ClinicalTrials.gov registry entry for NCT02928770 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Nastent is the first listed.
NCT02928770 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02928770 about?
NCT02928770 is a clinical study titled "A Disposable Device NAS to Treat Obstructive Sleep Apnea and Snoring". The purpose of this research study is to test a new approach for treating patients with obstructive sleep apnea and/or snoring. The new nasal device, nastent (NAS: nasal airway stent), appears to be a useful alternative or additive treatment.
What is the current status of trial NCT02928770?
This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2015-02. Estimated completion is 2017-12-31.
What interventions are being tested in trial NCT02928770?
The interventions under investigation include: Nastent (DEVICE).
Who is sponsoring clinical trial NCT02928770?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.